Publications by authors named "Qiu-Fen Xie"

Article Synopsis
  • The study developed a pharmacokinetic (PK) and pharmacodynamic (PD) model using data from healthy Chinese individuals and non-valvular atrial fibrillation (NVAF) patients to understand bleeding risks and drug effects.* -
  • The model utilized extensive data including dabigatran concentration and various coagulation tests from 285 participants, revealing strong correlations between PD biomarkers and bleeding events over a year.* -
  • Key findings indicated that fixed dabigatran doses could be safely administered to NVAF patients without adjusting for certain factors, while higher exposure levels correlated with increased bleeding risk, necessitating further randomized studies for efficacy in this population.*
View Article and Find Full Text PDF

This study compared the effect of indobufen with that of aspirin on platelet function in patients with stable coronary heart disease after percutaneous coronary intervention (PCI). Patients with stable coronary heart disease who had undergone PCI and received dual antiplatelet therapy (aspirin 100 mg + clopidogrel 75 mg once daily) for at least 12 months were allocated to receive indobufen 100 mg twice daily + clopidogrel 75 mg once daily, clopidogrel 75 mg once daily alone, indobufen 100 mg twice daily alone, and aspirin 100 mg once daily alone for 1 month each in an open-label crossover manner. Platelet function was assessed by using the rates of arachidonic acid (AA)-induced platelet aggregation (AA-PAR) and adenosine diphosphate (ADP)-induced platelet aggregation (ADP-PAR) measured by light transmission aggregometry, the platelet reactivity index measured by vasodilator-stimulated phosphoprotein (PRI-VASP), and the plasma and urinary thromboxane B (TXB) concentrations recorded at baseline and during each treatment phase.

View Article and Find Full Text PDF

Background: The real-world studies on recurrent venous thromboembolism (VTE) and bleeding events of non-vitamin K antagonist oral anticoagulants (NOACs) in VTE patients have reported conflicting findings. Our study aimed to provide the direct comparison evidence of different NOACs for VTE patients in clinical practice settings.

Methods: Search of the medical literature was conducted using PubMed, Web of Science, EMBASE, Clinical Trials.

View Article and Find Full Text PDF
Article Synopsis
  • A meta-analysis was conducted to examine the relationship between single-nucleotide polymorphisms (SNPs) and the risk of statin-induced myopathy (SIM), pulling data from 32 studies with a total of 21,692 individuals.
  • The findings indicated that the SLCO1B1 rs4149056 SNP is linked to an increased risk of SIM, while the rs4363657 variant is associated with a reduced risk, particularly in different statin treatments.
  • Overall, three specific SNPs (rs4149056, rs4363657, and rs9806699) were identified as significant factors influencing the likelihood of developing SIM in patients on statin medications.
View Article and Find Full Text PDF

The present study compared performances of the three major methods used for assessing platelet reactivity (PR)-VerifyNow, light transmission aggregometry (LTA) and thromboelastography (TEG)-to predict ischaemic events in patients receiving clopidogrel. PubMed, EMBASE and the Cochrane Library were searched from their inception to April 2019 for prospective studies that examined PR using VerifyNow, LTA or TEG and the incidence of ischaemic events. The investigated diagnostic indices include sensitivity, specificity, positive (PLR) and negative likelihood ratio (NLR), diagnostic odds ratio and area under the receiver operating characteristic curves (AUC) of VerifyNow, LTA and TEG, respectively.

View Article and Find Full Text PDF

Objective: Venous thromboembolism (VTE) is a common cardiovascular disease, in which pulmonary embolism (PE) is potentially life-threatening. Accurate biological markers for the early diagnosis of VTE are needed. The purpose of this study was to analyze and validate the predictive value of microRNAs for the diagnosis of VTE.

View Article and Find Full Text PDF

Background: Human leukocyte antigen (HLA) alleles are implicated in drug-induced hypersensitivity, including by nevirapine and abacavir. The purpose of this meta-analysis was to evaluate the relationship between HLA polymorphisms and hypersensitivity to antiretroviral therapy in human immunodeficiency virus (HIV)-infected patients.

Methods: We conducted a systematic search of PubMed, Embase, Web of Science, and the Cochrane Library for studies that evaluated the associations of HLA polymorphisms with antiretroviral therapy-induced hypersensitivity published in April 2019.

View Article and Find Full Text PDF

Numerous studies have illustrated the relationship between SLCO1B1 T521C polymorphism and statin-induced myopathy risk; however, this association is not consistent. Three electronic databases (PubMed, EMBASE, and the Cochrane Library) were searched from inception to October 2017 to identify potential studies. The summary odds ratios (ORs) with 95% confidence intervals (CIs) were calculated from different genetic models by using a random-effects model.

View Article and Find Full Text PDF

A multi-responsive sensor 1 was constructed by combining a ferrocene unit and a rhodamine block via a carbohydrazone bond. The sensor showed high selectivity toward Cu(2+) over other common metal ions in a wide pH range with excellent reversibility and rapid response. The obvious color change from colorless to pink upon the addition of Cu(2+) could make it a suitable 'naked-eye' indicator for Cu(2+).

View Article and Find Full Text PDF